Northpond Ventures — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
Cambridge, US
Clinton Hansen(Executive Officer, Promoter)Wesley Wong(Executive Officer, Director, Promoter)
Board seatSteve LiapisElias Quijano· per SEC Form D · $15M raise · filed Sep 2025
Elephas develops elive, a live-tissue platform technology that predicts immunotherapy response in cancer patients by measuring real-time immune activity in intact tumor tissue.
BiotechDigital HealthHealthtechMedical DevicesMadison, US
Jonathan Oliner(Executive Officer)inManeesh K. Arora(Executive Officer, Director, Promoter)Maneesh Arora(Founder)inMichelle B. Arora(Director)Terrence P. Brady(Executive Officer)
Co-investorsARCH Venture PartnersSands Capital Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.